Literature DB >> 28276604

One-step immunochromatographic visual assay for anti-transglutaminase detection in organ culture system: An easy and prompt method to simplify the in vitro diagnosis of celiac disease.

Marco Di Tola1,2, Mariacatia Marino1, Rossella Casale1, Raffaele Borghini1, Antonio Tiberti1, Giuseppe Donato3, Umberto Occhiuzzi2, Antonio Picarelli1.   

Abstract

BACKGROUND: Anti-tissue transglutaminase (anti-tTG) and endomysium antibodies (EMA) are detectable in duodenal culture media of celiac disease (CD) patients. To improve the management of this organ culture system, we evaluated the anti-tTG occurrence by immunochromatographic assay (ICA).
METHODS: A total of 103 CD patients and 41 disease controls underwent duodenal biopsy for the organ culture. In culture supernatants, IgA anti-tTG were tested by both enzyme-linked immunosorbent assay (ELISA) and ICA, IgA EMA were searched by indirect immunofluorescence analysis (iIFA).
RESULTS: Endomysium antibodies and anti-tTG measured by ELISA were positive in culture media of all CD patients, while anti-tTG detected by ICA were positive in culture media of 87/103 CD patients. Anti-tTG ICA scores significantly correlated with anti-tTG ELISA values (r=.71, P<.0001). Sensitivity, specificity and diagnostic accuracy of anti-tTG detected by ICA were 84.5%, 100% and 88.9%, respectively.
CONCLUSIONS: Using ICA, anti-tTG are detectable in duodenal culture media of most CD patients and the intensity of indicative lines depends on the anti-tTG concentration. Sensitivity and diagnostic accuracy achieved with ICA are lower than those obtained with ELISA but, given that the first is a more easy and prompt method, data suggest the possibility of utilizing it in the in vitro diagnosis of CD.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  anti-transglutaminase; celiac disease; diagnosis; immunochromatographic assay; organ culture system

Mesh:

Substances:

Year:  2017        PMID: 28276604      PMCID: PMC6817112          DOI: 10.1002/jcla.22195

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  21 in total

1.  In Vitro is less challenging to celiac children.

Authors:  H Julia Ellis; Paul J Ciclitira
Journal:  J Pediatr Gastroenterol Nutr       Date:  2005-02       Impact factor: 2.839

2.  Production of antiendomysial antibodies after in-vitro gliadin challenge of small intestine biopsy samples from patients with coeliac disease.

Authors:  A Picarelli; L Maiuri; A Frate; M Greco; S Auricchio; M Londei
Journal:  Lancet       Date:  1996-10-19       Impact factor: 79.321

3.  Usefulness of the organ culture system in the in vitro diagnosis of coeliac disease: a multicentre study.

Authors:  Antonio Picarelli; Marco Di Tola; Luigi Sabbatella; Maria Cristina Anania; Antonio Calabrò; Daniela Renzi; Julio Cesar Bai; Emilia Sugai; Antonio Carroccio; Lidia Di Prima; Maria Teresa Bardella; Donatella Barisani; Carmen Ribes-Koninckx; Ester Donat Aliaga; Maurizio Gasparin; Enzo Bravi
Journal:  Scand J Gastroenterol       Date:  2006-02       Impact factor: 2.423

4.  Anti-transglutaminase antibody assay of the culture medium of intestinal biopsy specimens can improve the accuracy of celiac disease diagnosis.

Authors:  Antonio Carroccio; Lidia Di Prima; Giuseppe Pirrone; Calogero Scalici; Ada M Florena; Maurizio Gasparin; Giuseppe Tolazzi; Antonino Gucciardi; Carmelo Sciumè; Giuseppe Iacono
Journal:  Clin Chem       Date:  2006-03-30       Impact factor: 8.327

5.  Anti-tissue transglutaminase antibodies in inflammatory bowel disease: new evidence.

Authors:  Marco Di Tola; Luigi Sabbatella; Maria Cristina Anania; Angelo Viscido; Renzo Caprilli; Roberta Pica; Paolo Paoluzi; Antonio Picarelli
Journal:  Clin Chem Lab Med       Date:  2004       Impact factor: 3.694

Review 6.  In Vitro Gluten Challenge Test for Celiac Disease Diagnosis.

Authors:  Maryam Khalesi; Seyed Ali Jafari; Mohammadali Kiani; Antonio Picarelli; Raffaele Borghini; Ramin Sadeghi; Alireza Eghtedar; Hosein Ayatollahi; Hamid R Kianifar
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-02       Impact factor: 2.839

7.  Celiac disease screening by immunochromatographic visual assays: results of a multicenter study.

Authors:  Luis Carlos Blesa Baviera; Ester Donat Aliaga; Luis Ortigosa; Néstor Litwin; Luis Peña-Quintana; Virginia Méndez; Ma Victoria González; Javier Manzanares López-Manzanares; Enrique Méndez; Carmen Ribes Koninckx
Journal:  J Pediatr Gastroenterol Nutr       Date:  2007-11       Impact factor: 2.839

Review 8.  Autoantibodies in celiac disease.

Authors:  Armin Alaedini; Peter H R Green
Journal:  Autoimmunity       Date:  2008-02       Impact factor: 2.815

9.  Usefulness of the organ culture system when villous height/crypt depth ratio, intraepithelial lymphocyte count, or serum antibody tests are not diagnostic for celiac disease.

Authors:  Antonio Picarelli; Marco Di Tola; Mariacatia Marino; Valerio Libanori; Raffaele Borghini; Elisa Salvi; Giuseppe Donato; Domenico Vitolo; Antonio Tiberti; Adriana Marcheggiano; Gabrio Bassotti; Enrico Corazziari
Journal:  Transl Res       Date:  2012-11-20       Impact factor: 7.012

10.  Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology.

Authors:  Jonas F Ludvigsson; Julio C Bai; Federico Biagi; Timothy R Card; Carolina Ciacci; Paul J Ciclitira; Peter H R Green; Marios Hadjivassiliou; Anne Holdoway; David A van Heel; Katri Kaukinen; Daniel A Leffler; Jonathan N Leonard; Knut E A Lundin; Norma McGough; Mike Davidson; Joseph A Murray; Gillian L Swift; Marjorie M Walker; Fabiana Zingone; David S Sanders
Journal:  Gut       Date:  2014-06-10       Impact factor: 23.059

View more
  1 in total

1.  One-step immunochromatographic visual assay for anti-transglutaminase detection in organ culture system: An easy and prompt method to simplify the in vitro diagnosis of celiac disease.

Authors:  Marco Di Tola; Mariacatia Marino; Rossella Casale; Raffaele Borghini; Antonio Tiberti; Giuseppe Donato; Umberto Occhiuzzi; Antonio Picarelli
Journal:  J Clin Lab Anal       Date:  2017-03-09       Impact factor: 2.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.